Gianluca Pirozzi
Directeur/Membre du Conseil chez TREX WIND-DOWN, INC.
Fortune : 1 $ au 31/03/2024
Postes actifs de Gianluca Pirozzi
Sociétés | Poste | Début | Fin |
---|---|---|---|
TREX WIND-DOWN, INC. | Directeur/Membre du Conseil | 01/05/2020 | - |
Independent Dir/Board Member | 01/05/2020 | - | |
ALEXION PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/10/2019 | - |
Historique de carrière de Gianluca Pirozzi
Anciens postes connus de Gianluca Pirozzi
Sociétés | Poste | Début | Fin |
---|---|---|---|
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | 01/09/2018 | 01/05/2020 |
Sanofi SA | Corporate Officer/Principal | 01/04/2014 | 01/09/2019 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Formation de Gianluca Pirozzi
Sapienza University of Rome | Doctorate Degree |
Università Campus Bio-Medico di Roma | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Italie | 3 |
France | 2 |
Opérationnelle
Director/Board Member | 2 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
TREX WIND-DOWN, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Health Technology |
Sanofi SA | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Gianluca Pirozzi
- Expérience